Overview

The Safety of Intravenous Lacosamide

Status:
Completed

Trial end date:
2012-11-01

Target enrollment:

Participant gender:

Summary

To evaluate the safety of IV Lacosamide in children with partial-onset epilepsy, ages 4-35 years old, inclusive, who are either unable to take oral medication or require intravenous administration of IV Lacosamide.

Phase:

Phase 4

Details

Lead Sponsor:

Le Bonheur Children's Hospital

Treatments:

Lacosamide